)
Misitano & Stracuzzi (MS) investor relations material
Misitano & Stracuzzi H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Operates globally in citrus transformation for juices, essential oils, and aromatic solutions, with a strong presence in healthy food and international markets.
H1 2026 closed with a net loss of €563k, impacted by a 10.4% drop in sales and lower margins.
Sales revenues for H1 2026 were €36.5 million, down from €40.7 million year-over-year, mainly due to weaker performance in the Americas region.
Gross margin improved to 26.7% of revenues from 22.9% at FY 2025 year-end, though lower than 28.6% in H1 2025.
Strategic investments in new production sites and R&D continue, with a focus on efficiency and product innovation.
Financial highlights
Revenue: €36.5M, down 10.4% year-over-year from €40.7M, mainly due to lower sales in the Americas.
EBITDA: €1.2M (3.2% margin), down 67.3% from €3.5M (8.6% margin) in H1 2025.
EBIT: €116k, down 95.5% from €2.6M.
Net loss: €563k vs. net profit of €1.68M in H1 2025.
Net financial position improved to -€38.6M from -€40.9M at year-end 2025.
Outlook and guidance
Financial restructuring agreement signed in September 2026, extending debt maturities and improving liquidity.
Management expects revenue growth from new high-margin products, international expansion, and operational efficiency from new facilities.
Cost optimization and efficiency measures underway to support profitability.
Launch of new production facility in San Filippo del Mela planned.
- Revenue up 17.9% but net loss and higher debt drive restructuring and efficiency focus.MS
H2 2025 - 2025 revenue will rise, but 2026 faces a 25% drop and halved EBITDA amid cost and demand pressures.MS
Q4 2025 TU - Revenue up 13.5% YoY, but margins and net profit declined amid rising input costs.MS
H1 2025 - Revenue and profit surged, supported by IPO proceeds and robust global demand.MS
H2 2024
)
)
)
)
)
)
)
)